Your browser doesn't support javascript.
loading
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
Derenzini, Enrico; Tabanelli, Valentina; Sammassimo, Simona; Mazzara, Saveria; Motta, Giovanna; Melle, Federica; Vanazzi, Anna; Calleri, Angelica; Fiori, Stefano; Finazzi, Maria Chiara; Barbanti, Maria Chiara; Ramadan, Safaa; Gandini, Sara; Pastano, Rocco; Rambaldi, Alessandro; Pileri, Stefano; Tarella, Corrado.
Afiliación
  • Derenzini E; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy. enrico.derenzini@ieo.it.
  • Tabanelli V; Department of Health Sciences, University of Milan, Milan, Italy. enrico.derenzini@ieo.it.
  • Sammassimo S; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Mazzara S; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Motta G; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Melle F; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Vanazzi A; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Calleri A; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Fiori S; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Finazzi MC; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Barbanti MC; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
  • Ramadan S; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
  • Gandini S; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Pastano R; Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Rambaldi A; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Pileri S; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
  • Tarella C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Bone Marrow Transplant ; 56(9): 2280-2283, 2021 09.
Article en En | MEDLINE | ID: mdl-33963303
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Italia